ANS Drugs part 2.pptx - NURS 761 Autonomic Nervous System Drugs Sympathetic Parasympathetic Agonists Antagonists \u2013 Part 2(Adrenergics Fall 2018

ANS Drugs part 2.pptx - NURS 761 Autonomic Nervous System...

This preview shows page 1 - 6 out of 20 pages.

NURS 761 Pharmacotherapeutics Autonomic Nervous System Drugs Sympathetic & Parasympathetic Agonists & Antagonists – Part 2 (Adrenergics) Fall 2018 Faculty: Dr. Cheryl Oetjen Dr. Carol Urban
Image of page 1
Learning Objectives 1. Identify the action and pharmacologic action of adrenergic agonists and antagonists. 2. Describe the clinical indications for adrenergic agonists and antagonists, including selective drugs. 3. Identify patients who are at increased risk for negative outcomes of pharmacotherapeutics with adrenergic agonist and antagonist drugs. 4. Develop a teaching plan to ensure optimal patient outcomes.
Image of page 2
Drugs to Know Adrenergic Agonists: epinephrine, pseudoephedrine (non-selective) phenylephrine, midodrine (alpha-1) albuterol, terbutaline (beta-2) clonidine, methyldopa (alpha-2 agonists) Adrenergic Antagonists prazosin, tamsulosin, silodosin, phentolamine (alpha-1 blockers) “-lol” (selective and nonselective beta blockers, some are also alpha-1 blockers)
Image of page 3
Adrenergic Agonists Sympathomimetic, include naturally occurring and synthetic catecholamines Three main effects: vasoconstriction, cardiac stimulation, bronchodilation Additional effects: nasal and ophthalmic decongestants
Image of page 4
Clinical Use Vasoactive effects : cardiac arrest, hypotension, heart failure,
Image of page 5
Image of page 6

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture